JSJCX
Price
$15.09
Change
+$0.11 (+0.73%)
Updated
Aug 21 closing price
Net Assets
547.47M
NRGSX
Price
$62.63
Change
+$0.26 (+0.42%)
Updated
Aug 21 closing price
Net Assets
7.39B
Interact to see
Advertisement

JSJCX vs NRGSX

JSJCX vs NRGSX Comparison Chart in %
View a ticker or compare two or three
VS
JSJCX vs. NRGSX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JSJCX is a Hold and NRGSX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
NRGSX has more cash in the bank: 7.39B vs. JSJCX (547M). NRGSX pays higher dividends than JSJCX: NRGSX (0.45) vs JSJCX (0.00). JSJCX was incepted earlier than NRGSX: JSJCX (8 years) vs NRGSX (13 years). JSJCX (2.14) is less costly to investors than NRGSX (0.74). JSJCX is a more actively managed with annual turnover of: 141.00 vs. NRGSX (23.00). NRGSX has a lower initial minimum investment than JSJCX: NRGSX (0) vs JSJCX (1000). JSJCX annual gain was more profitable for investors over the last year : -1.05 vs. NRGSX (-1.20). NRGSX return over 5 years is better than : -18.93 vs. JSJCX (-39.07).
JSJCXNRGSXJSJCX / NRGSX
Total Expense Ratio1.940.74262%
Annual Report Gross Expense Ratio2.140.74289%
Fund Existence8 years13 years-
Gain YTD8.40516.54351%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets547M7.39B7%
Annual Yield % from dividends0.000.45-
Returns for 1 year-1.05-1.2087%
Returns for 3 years24.327.14341%
Returns for 5 years-39.07-18.93206%
Returns for 10 yearsN/A12.86-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DB37.820.26
+0.69%
Deutsche Bank Aktiengesellschaft
UNF290.251.60
+0.55%
Unifirst Corp
FSBC45.150.11
+0.24%
Five Star Bancorp
CALC0.57-0.01
-1.78%
CalciMedica
RNA13.20-0.28
-2.08%
Atrium Therapeutics Inc.